1. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). (31st August 2019) Authors: Mach, François; Baigent, Colin; Catapano, Alberico L; Koskinas, Konstantinos C; Casula, Manuela; Badimon, Lina; Chapman, M John; De Backer, Guy G; Delgado, Victoria; Ference, Brian A; Graham, Ian M; Halliday, Alison; Landmesser, Ulf; Mihaylova, Borislava; Pedersen, Terje R; Riccardi, Gabriele; Ri... Journal: European heart journal Issue: Volume 41:Number 1(2020) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Apolipoprotein AV: gene expression, physiological role in lipid metabolism and clinical relevance. (August 2008) Authors: Prieur, Xavier; Huby, Thierry; Rodrííguez, Joan C; Couvert, Philippe; Chapman, M John Journal: Future lipidology Issue: Volume 3:Number 4(2008) Page Start: 371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy. (September 2008) Authors: Couvert, Philippe; Giral, Philippe; Dejager, Sylvie; Gu, Jessie; Huby, Thierry; Chapman, M John; Bruckert, Eric; Carriéé, Alain Journal: Pharmacogenomics Issue: Volume 9:Number 9(2008) Page Start: 1217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Beyond cardiovascular medicine: potential future uses of icosapent ethyl. (6th October 2020) Authors: Bhatt, Deepak L; Hull, Mark A; Song, Mingyang; Van Hulle, Carol; Carlsson, Cindy; Chapman, M John; Toth, Peter P Journal: European heart journal supplements Issue: Volume 22(2020)Supplement J Page Start: J54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel. Issue 10 (October 2016) Authors: Santos, Raul D; Gidding, Samuel S; Hegele, Robert A; Cuchel, Marina A; Barter, Philip J; Watts, Gerald F; Baum, Seth J; Catapano, Alberico L; Chapman, M John; Defesche, Joep C; Folco, Emanuela; Freiberger, Tomas; Genest, Jacques; Hovingh, G Kees; Harada-Shiba, Mariko; Humphries, Steve E; Jackson,... Journal: Lancet Issue: Volume 4:Issue 10(2016) Page Start: 850 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap. (6th October 2020) Authors: Parhofer, Klaus G; Chapman, M John; Nordestgaard, Børge G Journal: European heart journal supplements Issue: Volume 22(2020)Supplement J Page Start: J21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints—A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. (6th January 2020) Authors: Nordestgaard, Børge G; Langsted, Anne; Mora, Samia; Kolovou, Genovefa; Baum, Hannsjörg; Bruckert, Eric; Watts, Gerald F; Sypniewska, Grazyna; Wiklund, Olov; Borén, Jan; Chapman, M John; Cobbaert, Christa; Descamps, Olivier S; von Eckardstein, Arnold; Kamstrup, Pia R; Pulkki, Kari; Kronenberg, Flo... Journal: Clinical chemistry Issue: Volume 62:Number 7(2016) Page Start: 930 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of genetic variation in the SLCO1B1 gene on statin efficacy in low-density lipoprotein cholesterol-lowering therapy. (February 2011) Authors: Couvert, Philippe; Chapman, M John; Carriéé, Alain Journal: Pharmacogenomics Issue: Volume 12:Number 2(2011) Page Start: 137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of genetic variation in the SLCO1B1 gene on statin efficacy in low-density lipoprotein cholesterol-lowering therapy. (February 2011) Authors: Couvert, Philippe; Chapman, M John; Carriéé, Alain Journal: Pharmacogenomics Issue: Volume 12:Number 2(2011) Page Start: 137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges. Issue 17 (1st April 2021) Authors: Packard, Chris; Chapman, M John; Sibartie, Mahendra; Laufs, Ulrich; Masana, Luis Journal: Heart Issue: Volume 107:Issue 17(2021) Page Start: 1369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗